BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/12/2021 12:42:14 AM | Browse: 555 | Download: 1013
 |
Received |
|
2021-01-28 08:01 |
|
Peer-Review Started |
|
2021-01-28 08:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-06 18:37 |
|
Revised |
|
2021-03-17 14:57 |
|
Second Decision |
|
2021-06-16 08:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-06-16 11:27 |
|
Articles in Press |
|
2021-06-16 11:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-07-07 04:04 |
|
Publish the Manuscript Online |
|
2021-07-12 00:42 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hsuan Yeh, Chun-Cheng Chiang and Tzung-Hai Yen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chang Gung Memorial Hospital |
CORPG3K0191 |
| Chang Gung Memorial Hospital |
CMRPG3G0871 |
| Chang Gung Memorial Hospital |
CMRPG3G0872 |
|
| Corresponding Author |
Tzung-Hai Yen, MD, PhD, Doctor, Doctor, Professor, Department of Nephrology, Chang Gung Memorial Hospital, No. 199 Tung Hwa North Road, Taipei 105, Taiwan. m19570@adm.cgmh.org.tw |
| Key Words |
Hepatocellular carcinoma; Chronic kidney disease; End-stage renal disease; Hemodialysis; Cancer prognosis; Cancer therapeutics |
| Core Tip |
The varying degrees of renal dysfunction, from the various stages of chronic kidney disease to dialysis-dependent end-stage renal disease, often affect the choice of treatment and prognosis of patients with hepatocellular carcinoma (HCC). This complicates HCC treatment. This review encompasses the presumptive causes of the high degree of comorbidity of HCC and renal dysfunction, the impact of renal dysfunction on HCC prognosis, and the concerns that are specific to patients with pre-existing renal dysfunction for each stage of HCC treatment. |
| Publish Date |
2021-07-12 00:42 |
| Citation |
Yeh H, Chiang CC, Yen TH. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021; 27(26): 4104-4142 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i26/4104.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i26.4104 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
